A Clinical Trial to Access Pharmacokinetic Profiles and Safety of IVL3003.

Clinical trial NCT05345509 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05345509
Sponsor: Inventage Lab., Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2023-04-01
Primary completion: 2025-11-13
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.